Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
38%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
IHE
55
HOLDINGS
25%
ALSO IN FTXH
FTXH
51
HOLDINGS
26%
ALSO IN IHE
SECTOR DRIFT (IHE minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 24.0% | 7.8% | 7.8% |
|
JOHNSON & JOHNSON | 20.1% | 6.7% | 6.7% |
|
MERCK & CO. INC. | 4.4% | 7.1% | 4.4% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% | 6.8% | 4.1% |
|
VIATRIS, INC. | 5.0% | 4.0% | 4.0% |
IHE Overweight Relative to FTXH
|
ELI LILLY & CO | 16.2% |
|
JOHNSON & JOHNSON | 13.4% |
|
ROYALTY PHARMA PLC CLASS A | 5.2% |
|
AXSOME THERAPEUTICS, INC. | 2.6% |
|
ELANCO ANIMAL HEALTH, INC. | 2.3% |
|
CORCEPT THERAPEUTICS INC | 1.7% |
 |
JAZZ PHARMACEUTICALS PLC | 1.1% |
|
LIQUIDIA TECHNOLOGIES, INC. | 1.1% |
|
CRINETICS PHARMACEUTICALS INC | 1.0% |
|
ORGANON & CO. | 0.9% |
IHE Underweight Relative to FTXH
|
ABBVIE INC | -7.0% |
|
BIOGEN IDEC INC | -3.8% |
|
GILEAD SCIENCES INC | -3.4% |
|
VERTEX PHARMACEUTICALS INC | -3.3% |
|
AMGEN INC | -3.2% |
|
CARDINAL HEALTH INC | -3.2% |
|
UNITED THERAPEUTICS CORP | -3.1% |
|
REGENERON PHARMACEUTICALS | -2.9% |
|
MERCK & CO. INC. | -2.7% |
|
BRISTOL-MYERS SQUIBB CO | -2.7% |